RESUMO
Infection with genital Chlamydia while undergoing a vaginal instrumentation increases the risk of pelvic inflammatory disease with pain and sterility as sequelae. A literature study was performed in order to find out if screening and treatment for Chlamydia trachomatis should be offered to all women with miscarriages. This article reviews the available literature on the topic. The results show that there is a need for larger clinical trials before an evidence-based answer can be given.
Assuntos
Aborto Retido/microbiologia , Aborto Espontâneo/microbiologia , Infecções por Chlamydia/complicações , Infecções por Chlamydia/diagnóstico , Chlamydia trachomatis/isolamento & purificação , Medicina Baseada em Evidências , Feminino , Humanos , Infertilidade Feminina/microbiologia , Programas de Rastreamento , Doença Inflamatória Pélvica/microbiologia , Gravidez , Complicações Infecciosas na Gravidez/microbiologia , Esfregaço Vaginal/estatística & dados numéricosRESUMO
Although Candida species are frequent saprophytes of the female genital tract, chorioamnionitis or intrauterine fetal infections are rarely caused by these fungi. The present report describes a 34-year-old woman G2, P2, presenting with vaginal bleeding in the 11.6 weeks of gestation. Clinical and sonographic examination revealed a missed abortion and rested IUD. Histopathologically, a fungal chorioamnionitis due to Candida spp. was found at the curetting material, confirmed by detection of C. albicans infection on mycological culture. Foreign intrauterine bodies, like IUD's and cerclage sutures predispose to fungal chorioamnitis or fetal infections. This conditions urge repetetive search for Candida spp. to establish early anti-fungal therapy which may be therapeutic for this hithero rare intrauterine infection.